How well do polygenic risk scores identify men at high risk for prostate cancer? Systematic review and meta-analysis.
Clinical Genitourinary Cancer 2022; published online ahead of print
Secondary Treatment for Men with Localized Prostate Cancer: A Pooled Analysis of PRIAS and ERSPC-Rotterdam Data within the PIONEER Data Platform
J Pers Med 2022; 12(5): 751
Diagnostic and prognostic factors (DPFs) in patients with prostate cancer: a systematic review defining which DPFs are available in relation to the previously defined PIONEER COS
BMJ Open 2022; 12(4): e058267
Updating and Integrating Core Outcome Sets for Localised, Locally Advanced, Metastatic, and Nonmetastatic Castration-resistant Prostate Cancer: An Update from the PIONEER Consortium
Eur Urol 2022 Feb Online ahead of print
Diagnostic and prognostic factors in patients with prostate cancer: a systematic review protocol with the final aim being to develop an online search tool to present the DPFs identified
BMJ Open. 2021; 11(2): e040531
Standardising the Assessment of Patient-reported Outcome Measures in Localised Prostate Cancer. A Systematic Review by the PIONEER consortium
Eur Urol Oncol 2021 Nov Online ahead of print
The Key Role of Patient Involvement in the Development of Core Outcome Sets in Prostate Cancer. Read about our experience in patient engagment in PIONEER
Eur Urol Focus 2021 Sep;7(5):943-946
For a detailed overview of the PIONEER consortium, the project objectives and data sources read our latest Nature Reviews Urology editorial:
Nature Reviews Urology 2020 June; 17: 351-362
EU initiative on Digital Transformation of Health & Care aims to provide the conditions necessary for building a secure, flexible, and decentralized digital health infrastructure.
Genome Medicine 2020; 12:18
How the PIONEER project will unlock the power of big data and big data analytics to transform the diagnosis and treatment of prostate cancer in Health Europa Quarterly.
Issue 8 of Health Europa Quarterly